Search
News & Events
$1 million funding boost to help Aboriginal kids with skin infectionsThanks to a $1 million funding grant, Dr Asha Bowen from The Kids Research Institute Australia is on track to change Aboriginal children's skin infection statistics.
News & Events
Community is tackling FAS in the Fitzroy ValleyAmong the highest rates of Fetal Alcohol Syndrome (FAS) worldwide have been reported by Aboriginal community leaders in the remote Fitzroy Valley.
News & Events
Study shows the value of positive friends for Aboriginal kidsA new study has found that having a friend with good social skills and a supportive family may make a critical difference to the resilience of Aboriginal youth
News & Events
National Indigenous Immunisation Research WorkshopYou are invited to register to attend the National Indigenous Immunisation Research Workshop 2013: lessons learnt and future directions Workshop.
News & Events
Empowering Aboriginal communities the key to suicide preventionA comprehensive research report into the high rates of suicide in the Kimberley has called for a major change
News & Events
Aboriginal researchers achieve milestoneThe first Capacity Building Grant comprising solely of Indigenous researchers has been completed successfully
News & Events
Remote pools boost Aboriginal child healthA new study has found that swimming pools in remote Aboriginal communities can dramatically reduce rates of skin, ear and chest infections
News & Events
Children the key to breaking the cycle of disadvantageA national strategy that focuses on early child development is the key to breaking the cycle of Aboriginal poor health and disadvantage.
Research
Effective primary care management of type 2 diabetes for indigenous populations: A systematic reviewIndigenous peoples in high income countries are disproportionately affected by Type 2 Diabetes. Socioeconomic disadvantages and inadequate access to appropriate healthcare are important contributors.
Research
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAustralian First Nations children are at very high risk of early, recurrent, and persistent bacterial otitis media and respiratory tract infection. With the PREVIX randomised controlled trials, we aimed to evaluate the immunogenicity of novel pneumococcal conjugate vaccine (PCV) schedules.